“…We can emulate the endogenous signaling pathways that mediate the kinetic phase of the lytic cycle by treating isolated parasites with zaprinast, which stimulates PKG activation by inhibiting phosphodiesterases that degrade cGMP ( Brown et al, 2016 ; Lourido et al, 2012 ). Zaprinast-stimulated motility occurs rapidly and in defined sequence in apicomplexans: initially, an increase in cGMP activates parasite protein kinase G (PKG), which phosphorylates substrates and stimulates Ca 2+ release from internal stores ( Brown et al, 2020 ; Lourido and Moreno, 2015 ). PKG likely performs functions that extend beyond regulating Ca 2+ stores, for example by mobilizing diacylglycerol and phosphatidic acid ( Lourido et al, 2012 ; Brown et al, 2017 ; Bullen et al, 2016 ; Bisio et al, 2019 ); however, the use or phosphodiesterase inhibitors like zaprinast allows us to stimulate endogenous Ca 2+ release without flooding the cell with Ca 2+ , as is the case with ionophores.…”